Chairman of the occasion, Pastor Tunji Ayegbusi, described Divine Haemoglobin as a transformative work, urging sickle cell warriors and their families to embrace its guidance. “This book is more than ...

PRESS RELEASE AB SCIENCE PATENT FOR MASITINIB IN THE TREATMENT OF SICKLE CELL DISEASE FORMALLY GRANTED IN THE UNITED STATES WITH A PROTECTION UNTIL 2040 THIS DECISION STRENGTHENS MASITINIB’S ...

AB Science receives US patent for masitinib to treat sickle cell disease: Paris Friday, December 26, 2025, 14:00 Hrs [IST] AB Science SA, a pharmaceutical company specializing in ...

In place of our usual "What We Heard This Week" feature, and as part of our year-end wrap-ups, we've selected some of the ...

A report card on meeting goals of reducing activity and work limitations for people with arthritis delivers bleak news, but ...

An NGO urges the Nigerian government to classify sickle cell patients as disabled to ease their financial burden through ...

After a complex development process, Israel’s Ministry of Defense Directorate of Defense R&D (DDR&D) (MAFAT) and Rafael ...

On December 9, H.C. Wainwright analyst Patrick Trucchio reaffirmed his bullish stance on Beam Therapeutics (NASDAQ:BEAM).

As soon as you hear “new car smell,” you can feel it in your nostrils. Love it or loathe it, that distinctive odor is ...

AB Science (ABSCF) announced that the United States Patent Office has formally granted a patent for methods of treating sickle cell disease using ...

Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopeniaNovel treatment targets BTK through multi-immune ...

Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...